Medicare Enrolled
Dr. Tony Kurian, M.D.
Hematology · Venice, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kurian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kurian? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kurian
Dr. Tony Kurian is a hematology in Venice, FL, with 11 years in practice. Based on federal Medicare data, Dr. Kurian performed 194,230 Medicare services across 6,211 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kurian received a total of $8,651 from 65 pharmaceutical and/or device companies across 359 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kurian is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice▲ Top 22% volume in FL$ $8,651 industry payments
Medicare Practice Summary
Medicare Utilization ↗194,230
Medicare services
Top 22% in FL for hematology
6,211
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~17,657 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 32,130 | $0 | $4 |
| Nivolumab injection (Opdivo) | 19,260 | $24 | $72 |
| Contrast dye for imaging (iodine-based) | 15,841 | $0 | $1 |
| Filgrastim injection (Zarxio) for white blood cells | 14,760 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 13,680 | $43 | $137 |
| Filgrastim injection (Nivestym) for white blood cells | 12,660 | $0 | $1 |
| Epoetin alfa injection (Procrit) for anemia | 12,160 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 11,180 | $1 | $5 |
| Oxaliplatin chemotherapy injection | 8,160 | $0 | $12 |
| Denosumab injection (Prolia/Xgeva) | 7,980 | $18 | $51 |
| Daratumumab injection (Darzalex) | 7,560 | $38 | $110 |
| Immune globulin infusion (Gammagard) | 5,136 | $36 | $108 |
| Iron sucrose injection (Venofer) | 4,146 | $0 | $5 |
| Injection, eflapegrastim-xnst, 0.1 mg | 3,564 | $26 | $116 |
| Paclitaxel chemotherapy injection | 3,450 | $0 | $2 |
| Dexamethasone injection (steroid) | 2,900 | $0 | $3 |
| Iron infusion (Monoferric) | 2,800 | $16 | $57 |
| Complete blood count (CBC) with differential | 2,733 | $8 | $29 |
| Blood draw (venipuncture) | 2,713 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,400 | $1 | $28 |
| Office visit, established patient (30-39 min) | 1,171 | $96 | $339 |
| Drug injection, under skin or into muscle | 1,011 | $10 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 938 | $0 | $9 |
| Injection of additional new drug or substance into vein | 555 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 478 | $98 | $378 |
| Injection, leucovorin calcium, per 50 mg | 476 | $3 | $12 |
| Injection, fluorouracil, 500 mg | 428 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 326 | $47 | $189 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 310 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 298 | $22 | $84 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 285 | $16 | $59 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 282 | $3 | $205 |
| Injection, magnesium sulfate, per 500 mg | 238 | $1 | $2 |
| Injection, carboplatin, 50 mg | 203 | $2 | $41 |
| Administration of chemotherapy into vein, each additional hour | 176 | $22 | $79 |
| Injection, diphenhydramine hcl, up to 50 mg | 176 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 171 | $15 | $56 |
| Ct scan of chest with contrast | 160 | $53 | $344 |
| Infusion into a vein for hydration, each additional hour | 134 | $10 | $42 |
| Prothrombin time test (blood clotting) | 129 | $4 | $15 |
| CT scan of abdomen and pelvis with contrast | 122 | $173 | $550 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 120 | $55 | $206 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 111 | $400 | $680 |
| Office visit, established patient, complex (40-54 min) | 110 | $136 | $474 |
| Injection, zoledronic acid, 1 mg | 110 | $7 | $69 |
| Infusion, normal saline solution , 1000 cc | 102 | $2 | $7 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 91 | $1,097 | $3,709 |
| Red blood count automated, with additional calculations | 91 | $5 | $20 |
| Office visit, established patient (20-29 min) | 90 | $60 | $239 |
| Administration of additional new drug or substance into vein, 1 hour or less | 89 | $49 | $178 |
| New patient office visit, complex (60-74 min) | 82 | $163 | $585 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 82 | $137 | $562 |
| Infusion into a vein for hydration, 31-60 minutes | 75 | $25 | $156 |
| Injection of drug or substance into vein | 69 | $28 | $156 |
| Administration of additional new drug or substance into vein using push technique | 64 | $42 | $170 |
| Initial hospital admission, high complexity | 64 | $134 | $556 |
| Red blood count, automated test | 55 | $4 | $10 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 55 | $3 | $11 |
| Hospital follow-up visit, high complexity | 54 | $94 | $285 |
| New patient office visit (45-59 min) | 53 | $111 | $453 |
| Hospital follow-up visit, moderate complexity | 49 | $61 | $197 |
| Drawing of blood for a medical problem | 43 | $67 | $277 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 43 | $127 | $637 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 42 | $1 | $7 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 39 | $24 | $89 |
| CT scan of chest, without contrast | 29 | $46 | $350 |
| Nuclear medicine study whole body with ct scan | 27 | $1,096 | $3,706 |
| Administration of chemotherapy into vein using push technique | 27 | $74 | $303 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 22 | $15 | $56 |
| Automated urinalysis | 21 | $2 | $8 |
| Ct scan of soft tissue of neck with contrast | 16 | $65 | $704 |
| Ct scan of abdomen and pelvis without contrast | 14 | $72 | $391 |
| New patient office visit (30-44 min) | 11 | $72 | $298 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
21.3% high complexity
74.6% medium
4.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,651
Total received (2019-2024)
Avg $1,442/year across 6 years
Top 46% in FL for hematology
65
Companies
359
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,308 (96.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$343 (4.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,128
2023$3,381
2022$1,095
2021$416
2020$130
2019$501
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$598
AstraZeneca Pharmaceuticals LP
$592
Astellas Pharma US Inc
$474
Incyte Corporation
$424
Novartis Pharmaceuticals Corporation
$396
Daiichi Sankyo Inc.
$396
Celgene Corporation
$363
Genentech USA, Inc.
$354
Merck Sharp & Dohme LLC
$354
E.R. Squibb & Sons, L.L.C.
$285
Takeda Pharmaceuticals U.S.A., Inc.
$247
Lilly USA, LLC
$211
Gilead Sciences, Inc.
$210
Seagen Inc.
$205
Alexion Pharmaceuticals, Inc.
$190
BeiGene USA, Inc.
$188
JAZZ PHARMACEUTICALS INC.
$174
PFIZER INC.
$168
Bayer Healthcare Pharmaceuticals Inc.
$164
Eisai Inc.
$163
Mirati Therapeutics, Inc.
$136
ARRAY BIOPHARMA INC
$134
GlaxoSmithKline, LLC.
$132
SUN PHARMACEUTICAL INDUSTRIES INC.
$132
Exelixis Inc.
$117
Inari Medical, Inc.
$115
Kite Pharma, Inc.
$105
GENZYME CORPORATION
$99
Dendreon Pharmaceuticals LLC
$85
Genmab U.S., Inc.
$85
Acrotech Biopharma Inc.
$81
Pharmacyclics LLC, An AbbVie Company
$75
TAIHO ONCOLOGY, INC.
$69
Kyowa Kirin, Inc.
$66
Sumitomo Pharma America, Inc.
$61
Blueprint Medicines Corporation
$60
PharmaEssentia USA Corporation
$60
ARGENX US, INC.
$60
Amgen Inc.
$60
G1 Therapeutics, Inc.
$57
SOBI, INC
$57
EMD Serono, Inc.
$43
ABBVIE INC.
$43
Pharmacosmos Therapeutics Inc.
$43
Deciphera Pharmaceuticals Inc.
$39
RECORDATI_RARE_DISEASES_INC.
$38
Alnylam Pharmaceuticals Inc.
$38
CTI BioPharma Corp.
$33
Rigel Pharmaceuticals, Inc.
$31
Legend Biotech USA Inc.
$31
Regeneron Healthcare Solutions, Inc.
$30
Foundation Medicine, Inc.
$28
ImmunoGen, Inc.
$25
Fennec Pharmaceuticals, Inc.
$23
AVEO Pharmaceuticals, Inc.
$22
EUSA Pharma (US) LLC
$21
SERVIER PHARMACEUTICALS LLC
$20
Stemline Therapeutics Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$18
Agios Pharmaceuticals, Inc.
$18
Acrotech Biopharma LLC
$17
Progenics Pharmaceuticals, Inc.
$17
EISAI INC.
$16
Myovant Sciences Inc.
$14
Top 3 companies account for 19.2% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Alecensa · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · COSELA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · FLOWTRIEVER CATHETER · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · GIVLAARI · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NINLARO · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Odomzo · Orserdu · PADCEV · PANHEMATIN · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Pedmark · Perjeta · Polivy · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · Rezlidhia · S · SARCLISA · SCEMBLIX · Stivarga · Sylvant · TAGRISSO · TECVAYLI · TIVDAK · TUKYSA · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONVENDI · VYVGART · VYVGART HYTRULO · Venclexta · Vonjo · Vyloy · XALKORI · XOSPATA · Xospata · Xtandi · YONSA · Yescarta · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $4 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
21
Per 100K population
4.7
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL - VENICE
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kurian is a mixed practice specialist, with above-average Medicare volume (top 22% in FL), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kurian experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Kurian performed 32,130 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kurian receive payments from pharmaceutical companies?
Yes. Dr. Kurian received a total of $8,651 from 65 companies across 359 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kurian's costs compare to other hematologys in Venice?
Dr. Kurian's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kurian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Venice
Browse hematologys in Venice ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology